Studies using animal models have revealed that a podocyte-specific reduction in Tcf21 promotes both Focal Segmental glomerulosclerosis (FSGS)-like disease and an exaggerated DKD-like phenotype52. This evidence concerns the gene TCF21 and focal segmental glomerulosclerosis.